- Home
- ASC vs EBS Comparison
ASC vs EBS Comparison
Compare ASC & EBS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ASC
- EBS
- Stock Information
- Founded
- ASC 2010
- EBS 1998
- Country
- ASC Bermuda
- EBS United States
- Employees
- ASC N/A
- EBS N/A
- Industry
- ASC Marine Transportation
- EBS Biotechnology: Pharmaceutical Preparations
- Sector
- ASC Consumer Discretionary
- EBS Health Care
- Exchange
- ASC Nasdaq
- EBS Nasdaq
- Market Cap
- ASC 472.9M
- EBS 359.3M
- IPO Year
- ASC 2013
- EBS 2006
- Fundamental
- Price
- ASC $11.68
- EBS $7.62
- Analyst Decision
- ASC Buy
- EBS Strong Buy
- Analyst Count
- ASC 3
- EBS 3
- Target Price
- ASC $12.67
- EBS $14.33
- AVG Volume (30 Days)
- ASC 473.7K
- EBS 1.4M
- Earning Date
- ASC 07-30-2025
- EBS 08-06-2025
- Dividend Yield
- ASC 8.12%
- EBS N/A
- EPS Growth
- ASC N/A
- EBS N/A
- EPS
- ASC 1.04
- EBS 2.53
- Revenue
- ASC $324,200,000.00
- EBS $851,600,000.00
- Revenue This Year
- ASC N/A
- EBS N/A
- Revenue Next Year
- ASC N/A
- EBS $19.24
- P/E Ratio
- ASC $11.28
- EBS $3.02
- Revenue Growth
- ASC N/A
- EBS N/A
- 52 Week Low
- ASC $8.32
- EBS $4.02
- 52 Week High
- ASC $18.79
- EBS $12.73
- Technical
- Relative Strength Index (RSI)
- ASC 66.12
- EBS 42.09
- Support Level
- ASC $11.46
- EBS $8.16
- Resistance Level
- ASC $12.08
- EBS $8.62
- Average True Range (ATR)
- ASC 0.31
- EBS 0.39
- MACD
- ASC 0.04
- EBS -0.21
- Stochastic Oscillator
- ASC 77.01
- EBS 4.23
About ASC Ardmore Shipping Corporation
Ardmore Shipping Corp provides seaborne transportation of petroleum products and chemicals world-wide to oil majors, national oil companies, oil and chemical traders, and chemical companies, with its modern, fuel-efficient fleet of mid-size product and chemical tankers. The Company operates its business in one operating segment, the transportation of refined petroleum products and chemicals.
About EBS Emergent Biosolutions Inc.
Emergent BioSolutions Inc offers public health products to the government and healthcare providers. Company operates in three segments namely Commercial Product, MCM Products, and Services segment. The Commercial Product Segment consisting of Nasal Spray; the MCM Products Segment consisting of Anthrax-MCM products, Smallpox-MCM products and Other Products and the Services Segment consisting of Bioservices portfolio. The key revenue is generated through the commercial segment which consists of NARCAN and other commercial products.